Home » Tag Archives: RegMedNet

RegMedNet

FDA Issues New Draft Guidelines On Genome Editing And CAR-T Therapy

Car-T-Cell Therapy

CAR-T (chimeric antigen receptor T-cell) therapy is a relatively new blood cancer treatment that has, in some cases, cured patients where other treatments have failed. As CAR-T cells can stay active in the body for a long time, the therapy can be an effective one-time treatment, unlike many other blood cancer drugs that require multiple rounds. The therapy is specifically ...

Read More »